Traders bought shares of Mettler-Toledo International Inc. (NYSE:MTD) on weakness during trading on Friday. $81.89 million flowed into the stock on the tick-up and $66.35 million flowed out of the stock on the tick-down, for a money net flow of $15.54 million into the stock. Of all companies tracked, Mettler-Toledo International had the 26th highest net in-flow for the day. Mettler-Toledo International traded down ($0.63) for the day and closed at $600.37

MTD has been the subject of several analyst reports. Jefferies Group reiterated a “hold” rating and issued a $600.00 price target on shares of Mettler-Toledo International in a report on Friday, October 20th. Robert W. Baird boosted their price target on Mettler-Toledo International from $605.00 to $675.00 and gave the company a “neutral” rating in a report on Friday, November 3rd. Morgan Stanley boosted their price target on Mettler-Toledo International from $535.00 to $545.00 and gave the company an “equal weight” rating in a report on Friday, November 3rd. Zacks Investment Research downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Tuesday, November 7th. Finally, Evercore ISI initiated coverage on Mettler-Toledo International in a report on Wednesday, January 3rd. They set an “in-line” rating and a $625.00 price objective for the company. Six analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus target price of $656.44.

The firm has a market capitalization of $15,210.00, a price-to-earnings ratio of 36.43, a P/E/G ratio of 2.56 and a beta of 1.08. The company has a debt-to-equity ratio of 2.05, a current ratio of 1.51 and a quick ratio of 1.11.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, February 8th. The medical instruments supplier reported $5.97 EPS for the quarter, topping analysts’ consensus estimates of $5.93 by $0.04. The business had revenue of $778.03 million during the quarter, compared to the consensus estimate of $764.26 million. Mettler-Toledo International had a return on equity of 96.81% and a net margin of 16.44%. During the same period in the prior year, the firm posted $5.28 EPS. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. research analysts anticipate that Mettler-Toledo International Inc. will post 17.53 earnings per share for the current fiscal year.

In related news, insider Oliver A. Filliol sold 15,000 shares of the stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $631.51, for a total value of $9,472,650.00. Following the completion of the sale, the insider now directly owns 31,279 shares in the company, valued at approximately $19,753,001.29. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CFO Shawn Vadala sold 226 shares of the stock in a transaction on Monday, November 13th. The shares were sold at an average price of $629.36, for a total value of $142,235.36. Following the completion of the sale, the chief financial officer now owns 5,299 shares of the company’s stock, valued at $3,334,978.64. The disclosure for this sale can be found here. Over the last quarter, insiders sold 36,585 shares of company stock valued at $23,083,195. 5.20% of the stock is owned by insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Coastline Trust Co boosted its position in Mettler-Toledo International by 16.2% in the 3rd quarter. Coastline Trust Co now owns 575 shares of the medical instruments supplier’s stock valued at $360,000 after buying an additional 80 shares during the last quarter. Chartwell Investment Partners LLC boosted its position in Mettler-Toledo International by 4.1% in the 3rd quarter. Chartwell Investment Partners LLC now owns 2,104 shares of the medical instruments supplier’s stock valued at $1,317,000 after buying an additional 83 shares during the last quarter. Conning Inc. boosted its position in Mettler-Toledo International by 25.7% in the 4th quarter. Conning Inc. now owns 440 shares of the medical instruments supplier’s stock valued at $273,000 after buying an additional 90 shares during the last quarter. Candriam Luxembourg S.C.A. boosted its position in Mettler-Toledo International by 2.5% in the 3rd quarter. Candriam Luxembourg S.C.A. now owns 4,137 shares of the medical instruments supplier’s stock valued at $2,590,000 after buying an additional 100 shares during the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec boosted its position in Mettler-Toledo International by 2.9% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 3,600 shares of the medical instruments supplier’s stock valued at $2,264,000 after buying an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 91.93% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This news story was posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.dailypolitical.com/2018/02/09/investors-buy-shares-of-mettler-toledo-international-mtd-on-weakness.html.

About Mettler-Toledo International

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.